Clinical Trial Update: Chronic Obstructive Pulmonary Disease Endpoints Study [Phase 4]

View source ↗

Summary

This document reports an update on a Phase 4 COPD endpoints study sponsored by GlaxoSmithKline, noting the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED